SEC Filings - MiNK Therapeutics

Form	Description	Filing date	View
4	Statement of changes in beneficial ownership of securities	Jun 02, 2023	View HTML 0000899243-23-014414.pdf 0000899243-23-014414.rtf 0000899243-23-014414.xls
SC 13D/A	An amendment to a SC 13D filing	May 26, 2023	View HTML 0001193125-23-155541.pdf 0001193125-23-155541.rtf 0001193125-23-155541.xls
4/A	Amendment to a previously filed 4	May 26, 2023	View HTML 0000950170-23-024556.pdf 0000950170-23-024556.rtf 0000950170-23-024556.xls
4/A	Amendment to a previously filed 4	May 26, 2023	View HTML 0000950170-23-024567.pdf 0000950170-23-024567.rtf 0000950170-23-024567.xls
4/A	Amendment to a previously filed 4	May 26, 2023	View HTML 0000950170-23-024568.pdf 0000950170-23-024568.rtf 0000950170-23-024568.xls
4	Statement of changes in beneficial ownership of securities	May 12, 2023	View HTML 0000950170-23-021854.pdf 0000950170-23-021854.rtf 0000950170-23-021854.xls
8-K	Report of unscheduled material events or corporate event	May 11, 2023	View HTML 0001171843-23-003188.pdf 0001171843-23-003188.rtf 0001171843-23-003188.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
10-Q	Quarterly report which provides a continuing view of a company's financial position	May 11, 2023	View HTML 0000950170-23-021191.pdf 0000950170-23-021191.rtf 0000950170-23-021191.xls EX-101.LAB - XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
4	Statement of changes in beneficial ownership of securities	May 05, 2023	View HTML 0000950170-23-018401.pdf 0000950170-23-018401.rtf 0000950170-23-018401.xls
4	Statement of changes in beneficial ownership of securities	May 05, 2023	View HTML 0000950170-23-018413.pdf 0000950170-23-018413.rtf 0000950170-23-018413.xls

Data provided by Kaleidoscope.